CoRecover

CoRecover in South Portland, Maine offers Spravato (esketamine), an FDA-approved nasal spray for adults with treatment-resistant depression that has not improved with traditional medications. Spravato works differently than standard antidepressants by targeting glutamate pathways in the brain that support mood regulation and neural connectivity.

Treatment begins with a comprehensive evaluation of medical history, symptoms, and goals. During each visit, patients self-administer the nasal spray under supervision, receiving two to three spaced doses and remaining for two hours of monitoring. Care is delivered in private, comfortable treatment pods with dimmable lighting and an on-site clinical team.

Treatment typically starts with two sessions per week for four weeks, then steps down based on individual response. CoRecover focuses exclusively on FDA-approved esketamine rather than off-label or at-home ketamine.